Research shows dermatologists are overprescribing antibiotics for acne treatment, and patients and their parents seem unaware of the consequences, as well as alternatives to antibiotic treatment for acne.
Study demonstrates current antibiotic use for acne therapy far surpasses guideline recommendations and calls for dermatologists to decrease extended courses of antibiotics through early recognition of failure and guiding patients to alternative therapies.
Evidence from recently published papers provides insight to address some common questions pertaining to the safe use of certain acne medications. Learn more
There is an absence of strong evidence supporting the recommendation that cumulative dosing of isotretinoin follow a reference range of 120 to 150 mg/kg. This points to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.
Clinicians recognize that acne is increasingly presenting in pre-adolescents and that early presentation is also a predictor of worse disease in the future and the potential for scarring. Prompt, aggressive treatment will lead to better outcomes and will reduce the potential for adverse psychosocial effects.
The stories of the heroes behind these and other dermatologic therapeutic discoveries are recounted in the book To Heal the Skin: The Heroes Behind Discoveries in Dermatology edited by the late Stuart Maddin, M.D., F.R.C.P.C., professor emeritus at the University of British Columbia (UBC) in Vancouver, Canada, and a leader and pioneer in dermatology in Canada and internationally, and Eileen Murray, M.D., F.R.C.P.C., a dermatologist and adjunct professor at UBC. Learn more
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
New and exciting topical and oral therapeutic agents and those still in the pipeline are slated to revolutionize acne therapy, as they appear to more effectively improve the clinical symptoms of acne.
New research indicates that treatment results for patients with mild-to-moderate acne might be better with combinations of light colors with photodynamic therapy (PDT).
In part three of the discussion on isotretinoin, our experts discuss distinguishing sinus tracts or keratinous cysts from nodular areas of inflammation and techniques for treating via intralesional injection.